Bayer has completed the global acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals. “This acquisition is a milestone for Bayer and we intend to continue the expansion of our attractive over-the-counter business both through organic growth and bolt-on acquisitions,” explained … Continue reading Stock Runners : Merck & Co. Inc. (NYSE:MRK), Trinity Industries Inc. (NYSE:TRN), Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), WellCare Health Plans, Inc. (NYSE:WCG), LRAD